Sepsis and septic shock in pregnancy

Critical Care Clinics

Volumn 20, Issue 4, 2004, Pages 651-660

  Sheffield, Jeanne S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; AMINOGLYCOSIDE; ANTITHROMBIN; CLINDAMYCIN; CORTICOSTEROID; DROTRECOGIN; HEPARIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TISSUE FACTOR PATHWAY INHIBITOR; VANCOMYCIN;

BACTEROIDES; CLINICAL FEATURE; CLINICAL TRIAL; CLOSTRIDIUM; DISEASE ASSOCIATION; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; HUMAN; LISTERIA MONOCYTOGENES; MORTALITY; PATHOPHYSIOLOGY; PEPTOCOCCUS; PEPTOSTREPTOCOCCUS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS AERUGINOSA; REVIEW; SEPSIS; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS;

EID: 4544380419     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2004.05.012     Document Type: Review

References (34)

1. D.C. Angus, W.T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M.R. Pinsky Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care Crit Care Med 29 2001 1303 1310
2. R.S. Hotchkiss, and I.E. Karl The pathophysiology and treatment of sepsis N Engl J Med 348 2003 138 150
3. G.S. Martin, D.M. Mannino, S. Easton, and M. Moss The epidemiology of sepsis in the United States from 1979â€"2000 N Engl J Med 348 2003 1546 1554
4. W.C. Mabie, J.R. Barton, and B.M. Sibai Septic shock in pregnancy Obstet Gynecol 90 1997 553 561
5. E. Abraham, A. Anzveto, G. Gutierez, S. Tessler, G. Pedro, and R. Wunderink Double-blind randomized controlled trial of monoclonal antibody to human tumor necrosis factor in treatment of septic shock Lancet 351 1998 929 933
6. A.P. Wheeler, and G.R. Bernard Treating patients with severe sepsis N Engl J Med 340 1999 207 214
7. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 20 1992 864 874
8. M.M. Levy, M.P. Fink, J.C. Marshall, E. Abraham, D. Angus, and D. Cook The 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Crit Care Med 31 2003 1250 1256
9. K.E. Sands, D.W. Bates, P.N. Lanken, P.S. Gramam, P.L. Hibberd, and K.L. Kahn Epidemiology of sepsis syndrome in 8 academic medical centers: Academic Medical Center Consortium Sepsis Project Working Group JAMA 278 1997 234 240
10. E. Lolis, and R. Bucala Therapeutic approaches to innate immunity: severe sepsis and septic shock Nature Rev 2 2003 635 645
11. R.S. Munford, and J. Pugin The crucial role of systemic responses in the innate (non-adaptive) host defense J Endotoxin Res 7 2001 327 332
12. F.P. Ognibene, M.M. Parker, C. Natanson, J.H. Shelhamer, and J.E. Parrillo Depressed left ventricle performance: response to volume infusion in patients with sepsis and septic shock Chest 93 1988 903 910
13. D.C. Angus, R. Wunderink, J.-P. Mira, H. Gerlach, C.J. Wiedermann, and J.-L. Vincent The PIRO concept: P is for predisposition Crit Care Med 7 2003 248 251
14. G.P. Patel, D.P. Gurka, and R.A. Balk New treatment strategies for severe sepsis and septic shock Curr Opin Crit Care 9 2003 390 396
15. J.P. Mira, A. Cariou, F. Grall, C. Delclaux, M.R. Losser, and F. Heshmati Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study JAMA 282 1999 561 568
16. J.M. O'Brien, and E. Abraham New approaches to the treatment of sepsis Clin Chest Med 24 2003 521 548
17. E. Rivers, B. Nguyen, S. Havstad, J. Ressler, A. Muzzin, and B. Knoblich Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 2001 1368 1377
18. B.E. Kreger, D.E. Craven, and W.R. McCabe Gram-negative bacteremia: IV. Re-evaluation of clinical features and treatment in 612 patients Am J Med 68 1980 344 355
19. R.S. Munford Sepsis and septic shock E. Braunwald A.S. Fauci D.L. Kasper S.L. Hauser D.L. Longo J.L. Jameson Harrison's principles of internal medicine 15th edition 2001 McGraw-Hill New York 799 804
20. Pulmonary Artery Catheter Consensus Conference Consensus statement Crit Care Med 25 1997 910 925
21. S.H. Rolbin, G. Levinson, D.M. Shnider, D.R. Biehl, and R.G. Wright Dopamine treatment of spinal hypotension decreases uterine blood flow in the pregnant ewe Anesthesiology 51 1979 37 40
22. The Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome N Engl J Med 342 2000 1301 1308
23. C.L. Sprung, P.V. Caralis, E.H. Marcial, M. Pierce, M.A. Gelbard, and W.M. Long The effects of high-dose corticosteroids in patients with septic shock: a prospective controlled study N Engl J Med 311 1984 1137 1143
24. R.C. Bone, C.J. Fisher Jr, T.P. Clemmer, G.J. Slotman, C.A. Metz, and RA. Balk A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock N Engl J Med 318 1987 653 658
25. The Veterans Administration Systemic Sepsis Cooperative Study Group Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis N Engl J Med 317 1987 659 665
26. R. Lefering, and E.A. Neugebauer Steroid controversy in sepsis and septic shock: meta-analysis Crit Care Med 23 1995 1294 1303
27. D. Annane, V. Sebille, C. Charpentier, P.E. Bollaert, B. Francois, and J. Korach Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock JAMA 288 2002 862 871
28. G.R. Bernard, J.L. Vincent, P.F. Lateve, S.P. LaRosa, J.F. Dhainaut, and A. Lopez-Rodriguez Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 2001 699 709
29. B.L. Warren, A. Eid, P. Singer, S.S. Pillay, P. Carl, and I. Novak Caring for the critically ill patient: high-dose antithrombin III in severe sepsis: a randomized controlled trial JAMA 286 2001 1869 1878
30. E. Abraham Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis Crit Care Med 28 2000 S31 S33
31. ICOS Corporation Review committee recommends termination of phase 3 study of Pafaseâ€"rPAF-AHâ€"in severe sepsis Available at: http://www.corporate-ir.net/ireye/ir_site.zhtm?ticker= ICOS&script=410&layout=0&item_id=365376 Accessed February 13, 2003
32. G. van den Berghe, P. Wouters, F. Weekers, C. Verwaest, F. Bruyninckx, and M. Schetz Intensive insulin therapy in critically ill patients N Engl J Med 345 2001 1359 1367
33. P. Eggimann, and D. Pittet Infection control in the ICU Chest 120 2001 2059 2093
34. American College of Obstetricians and Gynecologists Septic shock Tech Bull 204 1996